Spinal cord stimulation as treatment for complex regional pain syndrome should be considered earlier than last resort therapy

Neuromodulation

Volumn 16, Issue 2, 2013, Pages 125-141

  Poree, Lawrence ^a   Krames, Elliot ^b   Pope, Jason ^c,d   Deer, Timothy R ^e   Levy, Robert ^f,g   Schultz, Louise ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Pacific Pain Treatment Centers   (United States)

^c Napa Pain Institute   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e West Virginia University School of Medicine Charleston   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

^h Touro University California   (United States)

Author keywords

Cost neutrality; efficacy; fiscal neutrality; pain treatment continuum; S.A.F.E. principles; safety; spinal cord stimulation

Indexed keywords

BACLOFEN; CLONIDINE; GUANETHIDINE; KETAMINE; METALLOTHIONEIN; MORPHINE; OMEGA CONOTOXIN MVIIA; PLACEBO;

ALGORITHM; ALLERGIC REACTION; ANALGESIA; ARTICLE; ATELECTASIS; BLINDNESS; CHRONIC PAIN; CLINICAL EFFECTIVENESS; COMPLEX REGIONAL PAIN SYNDROME; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DISKITIS; EPIDURAL HEMATOMA; EROSION; HOARSENESS; HUMAN; INFECTION; LIQUORRHEA; LUMBAR SYMPATHECTOMY; MORBIDITY; MOTOR DYSFUNCTION; NEURITIS; PARALYSIS; PREVALENCE; SAFETY; SENSORY DYSFUNCTION; SEROMA; SPINAL CORD STIMULATION;

ALGORITHMS; COMPLEX REGIONAL PAIN SYNDROMES; COST-BENEFIT ANALYSIS; HEALTH RESORTS; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; SPINAL CORD STIMULATION;

EID: 84875848951     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/ner.12035     Document Type: Article

References (146)

1. Yong CO, Bruehl SP,. Complex regional pain syndrome. Curr Treat Options Neurol 2003; 5: 499-511.
2. Inhofe PD, Garcia-Moral CA,. Reflex sympathetic dystrophy: a review of the literature and a long-term outcome study. Orthop Rev 1994; 23: 921-924.
3. Krames E,. Interventional pain management appropriate when less invasive therapies fail to provide adequate analgesia. Med Clin North Am 1999; 83: 787-808.
4. Krames E, Poree L, Deer T, Levy R,. Rethinking algorithms of pain care: the use of the S.A.F.E. principles. Pain Med 2009; 10: 1-5.
5. Krames E, Poree L, Levy R, Deer T,. Implementing the S.A.F.E. principles for the development of pain medicine therapeutic algorithms that include neuromodulation techniques. Neuromodulation 2009; 12: 104-113.
6. Krames E, Monis S, Poree L, Levy R, Deer T,. Using the SAFE principles for patients with failed back surgery syndrome. Neuromodulation 2011; 14: 299-311.
7. Ribbers GM, Geurts AC, Stam HJ, Mulder T,. Pharmacologic treatment of complex regional pain syndrome I: a conceptual framework. Arch Phys Med Rehabil 2003; 84: 141-146.
8. Sieweke N, Birklein F, Riedl B, et al. Patterns of hyperalgesia in complex regional pain syndrome. Pain 1999; 80: 171-177.
9. de Mos M, de Bruijn AGJ, Huygen FJPM, Dieleman JP, Stricker BHCh, Sturkenboom MCJM,. The incidence of complex regional pain syndrome: a population-based study. Pain 2007; 129: 12-20.
10. Schwartzman RJ, Kerrigan J,. The movement disorder of reflex sympathetic dystrophy. Neurology 1990; 40: 57-61.
11. van Hilten JJ, van de Beek WJ, Vein AA, van, Dijk JG, Middelkoop HA,. Clinical aspects of multifocal or generalized tonic dystonia in reflex sympathetic dystrophy. Neurology 2001; 56: 1762-1765.
12. Taken from the internet. http://www.guideline.gov/summary/summary.aspx? ss=15&doc-id=4117&nbr=3162.
13. Oki G, Wada T, Kosuke I, Hikono A, Kouichi S, et al. Metallothionein deficiency in the injured peripheral nerves of complex regional pain syndrome as revealed by proteomics. Pain 2012; 153 (3): 532-539.
14. Pappagallo M, Rosenberg AD,. Epidemiology, pathophysiology, and management of complex regional pain syndrome. Pain Pract 2001; 1: 11-20.
15. Bennet DS, Brookoff D,. Complex regional pain syndrome (reflex sympathetic dystrophy and causalgia) and spinal cord stimulation. Pain Med 2006; 7: S64-S96. doi: 10.1111/j.1526-4637.2006.00124.x.
16. Silas Weir Mitchell MD,. The physician who discovered causalgia. J Hand Surg [Am] 2004; 29: 181-187.
17. Merskey H, Bogduk N,. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Seattle, WA: IASP Press, 1994.
18. Reinders MF, Geertzen JHB, Dijkstra PU,. Complex regional pain syndrome type I: use of the International Association for the Study of Pain diagnostic criteria defined in 1994. Clin J Pain 2002; 18: 207-215.
19. Bruehl S, Harden RN, Galer BS, et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. Pain 1999; 81: 147-154.
20. Harden RN, Bruehl S, Galer BS, et al. Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive? Pain 1999; 83: 211-219.
21. Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR,. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med 2007; 8: 326-331.
22. Harden RN, Bruehl S, Perez Roberto SGM, et al. Validation of proposed diagnostic criteria (the "Budapest Criteria") for complex regional pain syndrome. Pain 2010; 150: 268-274.
23. Wasner G, Schattschneider J, Binder A, Baron R,. Complex regional pain syndrome-diagnostic, mechanisms, CNS involvement and therapy. Spinal Cord 2003; 41: 61-75.
24. Birklein F, Riedl B, Claus D, Neundorfer B,. Pattern of autonomic dysfunction in time course of complex regional pain syndrome. Clin Auton Res 1998; 8: 79-85.
25. Sandroni P, Low PA, Ferrer T, et al. Complex regional pain syndrome I (CRPS I): prospective study and laboratory evaluation. Clin J Pain 1998; 14: 282-289.
26. Bruehl S, Harden RN, Galer BS, et al. Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome? Pain 2002; 95: 119-124.
27. Kozin F, Soin JS, Ryan LM, Carrera GF, Wortmann RL,. Bone scintigraphy in the reflex sympathetic dystrophy syndrome. Radiology 1981; 138: 437-443.
28. Werner R, Davidoff G, Jackson MD, Cremer S, Ventocilla C, Wolf L,. Factors affecting the sensitivity and specificity of the three-phase technetium bone scan in the diagnosis of reflex sympathetic dystrophy syndrome in the upper extremity. J Hand Surg [Am] 1989; 14: 520-523.
29. Zyluk A,. The usefulness of quantitative evaluation of three-phase scintigraphy in the diagnosis of post-traumatic reflex sympathetic dystrophy. J Hand Surg Br 1999; 24: 16-21.
30. Wuppenhorst N, Maier C, Frettloh J, Pennekamp W, Nicolas V,. Sensitivity and specificity of 3-phase bone scintigraphy in the diagnosis of complex regional pain syndrome of the upper extremity. Clin J Pain 2010; 26: 182-189.
31. Weiss L, Alfano A, Bardfeld P, Weiss J, Friedmann LW,. Prognostic value of triple phase bone scanning for reflex sympathetic dystrophy in hemiplegia. Arch Phys Med Rehabil 1993; 74: 716-719.
32. Demangeat JL, Constantinesco A, Brunot B, Foucher G, Farcot JM,. Three-phase bone scanning in reflex sympathetic dystrophy of the hand. J Nucl Med 1988; 29: 26-32.
33. Cappello ZJ, Kasdan ML, Louis DS,. Meta-analysis of imaging techniques for the diagnosis of complex regional pain syndrome type I. J Hand Surg [Am] 2012; 37: 288-296.
34. Sandroni P, Benrud-Larson LM, McClelland RL, Low PA,. Complex regional pain syndrome type I: incidence and prevalence in Olmsted County, a population-based study. Pain 2003; 103: 199-207.
35. Veldman PH, Reynen HM, Arntz IE, Goris RJ,. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 1993; 342: 1012-1016.
36. Allen G, Galer BS, Schwartz L,. Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain 1999; 80: 539-544.
37. Janig W, Baron R,. Complex regional pain syndrome is a disease of the central nervous system. Clin Auton Res 2002; 12: 150-164.
38. Van de Beek WJT, Roep BO, van der, Slik AR, Giphart MJ, van, Hilten BJ,. Susceptibility loci for complex regional pain syndrome. Pain 2003; 103: 93-97.
39. Oaklander AL, Rissmiller JG, Gelman LB, et al. Evidence of focal small-fiber axonal degeneration in complex regional pain syndrome-I (reflex sympathetic dystrophy). Pain 2006; 120: 235-243.
40. Albrecht PJ, Hines S, Eisenberg E, et al. Pathological alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome. Pain 2006; 120: 244-266.
41. Janig W, Baron R,. Is CRPS a neuropathic pain syndrome? Pain 2006; 120: 227-229.
42. McCabe CS, Haigh RC, Ring EFJ, et al. A controlled pilot study of the utility of mirror visual feedback in the treatment of complex regional pain syndrome (type 1). Rheumatology (Oxford) 2003; 42: 97-101.
43. Complex regional pain syndrome: a review of evidence-supported treatment options. Curr Pain Headache Rep 2003; 7: 188-196.
44. Kumar K, Rizvi S, Bnurs SB,. Spinal cord stimulation is effective in management of complex regional pain syndrome I: fact or fiction. Neurosurgery 2011; 69: 566-580.
45. Stanton-Hicks MD, Burton AW, Bruehl SP, et al. An updated interdisciplinary clinical pathway for CRPS: report from an expert panel. Pain Pract 2002; 2: 1-16.
46. Harbut RE, Graeme E, Correll BE,. Successful treatment of a nine-year case of complex regional pain syndrome type-I (reflex sympathetic dystrophy) with intravenous ketamine-infusion therapy in a warfarin-anticoagulated adult female patient. Pain Med 2002; 3: 147-155.
47. Kiefer RT, Rohr P, Ploppa A, et al. A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patients. Pain Med 2008; 9: 44-54.
48. Goldberg ME, Domsky R, Scaringe D, et al. Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome. Pain Physician 2005; 8: 175-179.
49. Yanow J, Pappagallo M, Pillai L,. Complex regional pain syndrome (CRPS/RSD) and neuropathic pain: role of intravenous bisphosphonates as analgesics. Scientific World Journal 2008; 8: 229-236.
50. Breure B, Pappagallo M, Ongseng F, Chen CI, Goldfarb R,. An open-label pilot trial of ibandronate for complex regional pain syndrome. Clin J Pain 2008; 24: 265-289.
51. Ching DWT, McClintock A, Beswick F,. Successful treatment with low-dose thalidomide in a patient with both Behcet's disease and complex regional pain syndrome type I: case report. J Clin Rheumatol 2003; 9: 96-98.
52. Rowbotham MC,. Pharmacologic management of complex regional pain syndrome. Clin J Pain 2006; 22: 425-429.
53. Harden RN,. Complex regional pain syndrome. Br J Anaesth 2001; 87: 99-106.
54. Sahin F, Yilmaz F, Kotevoglu N, Kuran B,. Efficacy of salmon calcitonin in complex regional pain syndrome (type 1) in addition to physical therapy. Clin Rheumatol 2005; 25: 143-148.
55. Schwartzman RJ, Liu JE, Smulles SN, Hyslop T, Tahmoush AJ,. Long term outcome following sympathectomy for complex regional syndrome type 1 (RSD). J Neurol Sci 1997; 150: 149-152.
56. Bandyk DF, Johnson BL, Kirkpatrick AF, et al. Surgical sympathectomy for reflex sympathetic dystrophy syndromes. J Vasc Surg 2002; 35: 269-277.
57. Tasker R,. Reflex sympathetic dystrophy-neurosurgical approaches. In:, Stanton -Hicks M, Janig W, Boas R, eds. Reflex sympathetic dystrophy. Boston, MA: Kluwer Academic Publishers, 1990: 124-134.
58. Carr DB, Cepeda MS, Lau J,. What is the evidence that for the therapeutic role of local anesthetic sympathetic blockade in RSD or causalgia? An attempted meta-analysis (abstract). In: Eighth world congress on pain. Seattle, WA: IASP, 1996: 406.
59. Schott GD,. Visceral afferents: their contribution to "sympathetic dependent" pain. Brain 1994; 117: 397-413.
60. Jadad AR, Carroll D, Glynn CJ, McQuay HJ,. Intravenous regional sympathetic blockade for pain relief in sympathetic dystrophy: a systematic review and a randomized double-blind crossover study. J Pain Symptom Manage 1995; 10: 13-20.
61. Ackerman L, Follett K, Rosenquist R,. Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. J Pain Symptom Manage 2003; 26: 668-677.
62. Zuniga RE, Perra S, Abram SE,. Interthecal baclofen: a useful agent in the treatment of well established complex regional pain syndrome. Reg Anesth Pain Med 2002; 27: 90-93.
63. Stanton-Hicks M, Kapural L,. An effective treatment of severe complex regional pain syndrome type 1 in a child using high doses of intrathecal ziconotide. J Pain Symptom Manage 2006; 32: 509-511.
64. Ushida T, Toshikazu T, Tetsuya K, et al. Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1. Reg Anesth Pain Med 2002; 27: 524-528.
65. Finch PM, Knudsed L, Drummond PD,. Reduction of allodynia in patients with complex regional pain syndrome: a double-blind placebo-controlled trial of topical ketamine. Pain 2009; 146: 18-25.
66. Schwartzman RJ, Alexander GM, Grothusen JR, et al. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain 2009; 147: 107-115.
67. Azari P, Lindsay DR, Briones D, et al. Efficacy and safety of ketamine in patients with complex regional pain syndrome: a systematic review. CNS Drugs 2012; 26: 215-228.
68. Taken from the internet, October 30, 2008. Wikipedia. http://en.wikipedia.org/wiki/Leyden-jar
69. Melzack K, Wall PD,. Pam mechanism®: a new theory. Science 1965; 150: 971-979.
70. Shealy CM, Mortimer JT, Reswick JB,. Electrical inhibition of pain by stimulation of the dorsal columns. Anesth Analg 1967; 46: 489-491.
71. Linderoth B, Foreman RD,. Physiology of spinal cord stimulation: review and update. Neuromodulation 2002; 2: 150-164.
72. Cui JG, Meyerson BA, Sollevi A, Linderoth B,. Effects of spinal cord stimulation on tactile hypersensitivity in mononeuropathic rats is potentiated by GABA-B and adenosine receptor activation. Neurosci Lett 1998; 247: 183-186.
73. Meyerson BA, Cui J-G, Yakhnitsa V, et al. Modulation of spinal pain mechanisms by spinal cord stimulation and the potential role of adjuvant pharmacotherapy. Stereotact Funct Neurosurg 1997; 68: 129-140.
74. Larson SJ, Sances A Jr, Riegel DH, et al. Neurophysiological effects of dorsal column stimulation in man and monkey. J Neurosurg 1974; 41: 217-223.
75. Saade NE, Tabet MS, Soueidan SA, Bitar M, Atweh SF, Jabbur SJ,. Supraspinal modulation of nociception in awake rats by stimulation of the dorsal column nuclei. Brain Res 1986; 369: 307-310.
76. Linderoth B, Fedorcsak I, Meyerson BA,. Is vasodilatation following dorsal column stimulation mediated by antidromic activation of small diameter fibers? Acta Neurochir Suppl 1989; 46: 99-101.
77. Krames E,. Spinal cord stimulation: indications, mechanism of action, and efficacy. Curr Pain Headache Rep 1999; 3: 419-426.
78. Singh G,. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998; 105: 31S-38S.
79. Wolfe MM, Lichtenstein DR, Singh G,. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999; 340: 1888-1899.
80. Fennerty MB,. NSAID-related gastrointestinal injury: evidence-based approach to a preventable complication. Postgrad Med 2001; 110: 87-89.
81. Daniell HW,. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain 2008; 9: 28-36.
82. Daniell HW,. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002; 3: 377-384.
83. Daniell HW,. DHEAS deficiency during consumption of sustained-action prescribed opioid-evidence for opioid-induced inhibition of adrenal androgen production. J Pain 2006; 7: 901-907.
84. Panchal SJ, Muller-Schweffe P, Wurzelmann JI,. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract 2007; 61: 1181-1187.
85. Banning A, Sjogren P,. Cerebral effects of long-term oral opioids in cancer patients measured by continuous reaction time. Clin J Pain 1990; 6: 91-95.
86. Bowen JD, Larson EB,. Drug-induced cognitive impairment. Defining the problem and finding solutions. Drugs Aging 1993; 3: 349-357.
87. Chapman S,. The effects of opioids on driving ability in patients with chronic pain. Am Pain Soc Bull 2001; 11: 1-5.
88. Galski T, Williams JB, Ehle HT,. Effects of opioids on driving ability. J Pain Symptom Manage 2000; 19: 200-208.
89. McCrimmon DR, Alheid GF,. On the opiate trail of respiratory depression. Am J Physiol Regul Integr Comp Physiol 2003; 285: R1274-R1275.
90. Paulozzi LJ, Budnitz DS, Yongli X,. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006; 15: 618-627.
91. Stanton-Hicks M,. Complications of sympathetic blocks for extremity pain. Tech Reg Anesth Pain Manag 2007; 11: 148-151.
92. Kumar K, Wilson JR, Taylor RS, Gupta S,. Complications of SCS, suggestions to improve outcome, and financial impact. J Neurosurg 2006; 5: 191-203.
93. Cameron T,. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20 years review. J Neurosurg (Spine 3) 2004; 100: 254-267.
94. Levy R, Henderson J, Slavin K, et al. Incidence and avoidance of neurologic complications with paddle type spinal cord stimulation leads. Neuromodulation 2011; 14: 412-422.
95. North RB, Kidd DH, Zahurak M, James CS, Long DM,. Spinal cord stimulation for chronic intractable pain: experience over two decades. Neurosurgery 1993; 32: 384-395.
96. Beltrutti D, Lamberto A, Barolat G, et al. The psychological assessment of candidates for spinal cord stimulation for chronic pain management. Pain Pract 2004; 4: 204-221.
97. Long D, Erickson D, Campbell J, North R,. Electrical stimulation of the spinal cord and peripheral nerves for pain control. Appl Neurophysiol 1981; 44: 207-217.
98. De La Porte C, Van de Kelfe E,. SCS in failed back surgery syndrome. Pain 1993; 52: 55-61.
99. Gybels J, Erdine S, Maeyaert J, et al. Neuromodulation of pain. A consensus statement prepared by a task force of the European Federation of IASP Chapters (EFIC). Eur J Pain 1998; 2: 203-209.
100. Heckler DR, Gatchel RJ, Lou L, Whitwork T, Bernstein D, Stowell AW,. Presurgical behavioral medicine evaluation (PBME) for implantable devices for pain management: a 1-year prospective study. Pain Pract 2007; 7: 110-122.
101. Williams KA, Gonzalez-Fernandez M, Hamzehzadeh S, et al. A multi-center analysis evaluating factors associated with spinal cord stimulation outcome in chronic pain patients. Pain Med 2011; 12: 1142-1153.
102. Cousins MJ,. Foreword. In:, Fordyce WE, ed. Back pain in the workplace: management of disability in nonspecific conditions task force report. Seattle, WA: International Association for the Study of Pain Press, 1995.
103. Turk DC, Burwinkle TM,. Clinical outcomes, cost-effectiveness, and the role of psychology in treatments for chronic pain sufferers. Prof Psychol Res Pr 2005; 36: 602-610.
104. Catlin A, Cowan C, Heffler S, et al. National health spending in 2005. Health Aff (Millwood) 2006; 26: 142-153.
105. Borger C, Smith S, Truffer C, et al. Health spending projections through 2015: changes on the horizon. Health Aff (Millwood) 2006; 25: W61-W73.
106. Gatchel RJ, Okifuji A,. Evidence-based scientific data documenting the treatment and cost-effectiveness of comprehensive pain programs for chronic nonmalignant pain. J Pain 2006; 7: 779-793.
107. Iglehart JK,. Opinion polls on health care. N Engl J Med 1984; 310: 1616-1620.
108. Blendon RJ, Altman DE,. Public attitudes about health-care costs; a lesson in national schizophrenia. N Engl J Med 1984; 311: 613-616.
109. Shiroiwa T, Sung YK, Fukuda T, et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 2010; 19: 422-437.
110. Kumar K, Malik S, Denny D,. Treatment of chronic pain with SCS versus alternative therapies: cost-effectiveness analysis. Neurosurgery 2002; 51: 106-116.
111. Bell G, Kidd D, North R,. Cost-effectiveness analysis of spinal cord stimulation in treatment of failed back surgery syndrome. J Pain Symptom Manage 1997; 13: 286-295.
112. Willis KD,. A simple approach to outcomes assessment of the therapeutic and cost-benefit success rates for spinal cord stimulation therapy. Anesthesiol Clin North America 2003; 21: 817-823.
113. Taylor R, Van Buyten J, Buchser E, et al. Spinal cord stimulation for complex regional pain syndrome: a systematic review of the clinical and cost-effectiveness literature and assessment of prognostic factors. Eur J Pain 2006; 10: 91-101.
114. Taylor R,. Spinal cord stimulation in complex regional pain syndrome and refractory neuropathic back and leg pain/failed back surgery syndrome: results of a systematic review and meta-analysis. J Pain Symptom Manage 2006; 31: S13-S19.
115. Kemler MA, Furnée CA,. Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology 2002; 59: 1203-1209.
116. Bedder MD, Burchiel K, Larson A,. Cost analysis of two implantable narcotic deliver systems. J Pain Symptom Manage 1991; 6: 368-373.
117. Mueller-Schweffe G, Hassenbusch SJ, Reig E,. Cost effectiveness of intrathecal therapy for pain neuromodulation. Neuromodulation 1999; 2: 77-87.
118. Hassenbusch SJ, Paice JA, Patt RB, Bedder MD, Bell GK,. Cost effectiveness of intrathecal therapy. J Pain Symptom Manage 1997; 14 (Suppl): S36-S48.
119. Lissovoy G, Brown RE, Halpern M, Hassenbusch SJ, Ross E,. Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome. Clin Ther 1997; 19: 96-112.
120. Kumar K, Hunter G, Demeria DD,. Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysis. J Neurosurg 2002; 97: 803-810.
121. North RB, Kidd D, Shipley J, Taylor R,. SCS versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized controlled trial. Clinical studies. Neurosurgery 2007; 61: 361-369.
122. Andrell P, Ekre O, Eliasson T, et al. Cost-effectiveness of SCS versus coronary artery bypass grafting in patients with severe angina pectoris-long-term results from the ESBY study. Cardiology 2003; 99: 20-24.
123. Taylor RJ, Taylor RS,. SCS for failed back surgery syndrome: a decision-analytic model and cost-effectiveness analysis. Int J Technol Assess Health Care 2005; 21: 351-358.
124. Taylor RS, Taylor RJ, Van Buyten JP, Buschser E, North R, Bayliss S,. The cost effectiveness of SCS in the treatment of pain: a systemic review of the literature. J Pain Symptom Manage 2004; 27: 370-378.
125. Rosenow JM, Stanton-Hicks M, Rezai AR, Henderson JM,. Failure modes of spinal cord stimulation hardware. J Neurosurg Spine 2006; 5: 183-190.
126. Turner JA, Loeser JD, Deyo RA, Sanders SB,. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a systematic review of effectiveness and complications. Pain 2004; 108: 137-147.
127. Henderson JM, Schade CM, Sasaki J, Caraway DL, Oakley JC,. Prevention of mechanical failures in implanted SCS systems. Neuromodulation 2006; 9: 183-191.
128. North RB, Kidd DH, Petrucci L, Dorsi MJ,. SCS electrode design: a prospective, randomized, controlled trial comparing percutaneous with laminectomy electrodes: part II-clinical outcomes. Neurosurgery 2005; 57: 990-996.
129. Follett KA, Boortz-Marx R, Drako JM, et al. Prevention and management of intrathecal drug delivery and SCS system infections. Anesthesiology 2004; 100: 1582-1594.
130. Simpson E, Duenas A, Holmes M, Papaioannou D, Chilcott J,. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation. Health Technol Assess 2009; 13: 1-179.
131. Hornberger J, Kumar K, Verhulst E, Clark MA, Hernandez J,. Rechargeable SCS versus nonrechargeable system for patients with failed back surgery syndrome: a cost-consequences analysis. Clin J Pain 2008; 24: 244-252.
132. Greenhalgh T,. How to read a paper. Taken from the internet http://books.google.com/books?hl=en&lr=&id=-5a0UyIOx-MC&oi= fnd&pg=PR9&dq=rules+of+evidence+based+medicine&ots= D5oSFrIGUC&sig=g4glNiB-H1hFtSq8U-8zOSfEdgc#PPP1,M1.
133. Mailis-Gagnon A, Furlan AD, Sandoval JA, Taylor R,. SCS for chronic pain. Cochrane Database Syst Rev 2004;(3): CD003783.
134. Moher D, Jadad AR, Tugwell P,. Assessing the quality of randomized controlled trials: current issues and future directions. Int J Technol Assess Health Care 1996; 12: 195-208.
135. Kemler MA, Barendse G, van, Kleer M, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med 2000; 343: 618-624.
136. Kemler MA, De Vet HCW, Barendse GAM, et al. The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Ann Neurol 2003; 55: 13-18.
137. Kemler MA, de Vet HC, Barendse GA, van den, Wildenberg FA, van, Kleef M, et al. Effect of spinal cord stimulation for chronic complex regional pain syndrome type I: five-year follow-up. N Engl J Med 2006; 354: 2394-2396.
138. Harke H, Gretenkort P, Ladleif HU, et al. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study. Anesth Analg 2001; 92: 488-495.
139. Sears NC, Machado AG, Nagel SJ, et al. Long-term outcomes of spinal cord stimulation with paddle leads in the treatment of complex regional pain syndrome and failed back surgery syndrome. Neuromodulation 2011; 14: 312-318.
140. Kumar K, Nath RK, Toth C,. SCS is effective in the management of reflex sympathetic dystrophy. Neurosurgery 1997; 40: 503-509.
141. Calvillo O, Racz G, Didie J, Smith K,. Neuroaugmentation in the treatment of CRPS of the upper extremity. Acta Orthop Belg 1998; 64: 57-61.
142. Bennett D, Alo K, Oakley J, Feler C,. SCS for CRPS I [RSD]: a retrospective multicenter experience from 1995 to 1998 of 101 patients. Neuromodulation 2002; 2: 202-210.
143. Van Buyten JP, VanZundert J, Vueghs P, Vanduffel L,. Efficacy of SCS: 10 years of experience in a pain centre in Belgium. Eur J Pain 2001; 5: 299-307.
144. Oakley JC, Weiner RL,. SCS for CRPS: a prospective study of 19 patients at two centers. Neuromodulation 2002; 2: 47-50.
145. Farouzanfar T, Kemler MA, Weber WEJ,., Kessels AGH, van, Kleef M,. SCS in CRPS: cervical and lumbar devices are comparably effective. Br J Anaesth 2004; 92: 348-353.
146. Harke H, Gretenkort P, Ladleif HU, Rahman S,. SCS in sympathetically maintained CRPS type I with severe disability. A prospective clinical study. Eur J Pain 2005; 9: 363.